Ioanna Zografou, Christos Sampanis, Eugenia Gkaliagkousi, Fotios Iliadis, Athanasios Papageorgiou, Panagiotis Doukelis, Konstantinos Vogiatzis, Stella Douma
OBJECTIVE: To evaluate the effect of dipeptidyl-peptidase-4 (DPP-4) inhibitor vildagliptin on high sensitivity C-reactive protein (hsCRP) and arterial stiffness (AS) in patients with type 2 diabetes (T2DM). DESIGN: Sixty-four drug-naive diabetic patients, with inadequate glycemic control …